Coexpression of hepatocyte growth factor and its receptor (c-met oncogene) in HGL4 glioblastoma cells

Oncology. 1996 Nov-Dec;53(6):511-6. doi: 10.1159/000227628.

Abstract

Many recent studies have shown that hepatocyte growth factor (HGF) is pleiotropic. Indeed, HGF has been reported to act as a mitogen and a morphogen as well as a mitogen. To evaluate the biological significance of HGF in many cell types of different origin, we tested 32 cell lines for expression of HGF mRNA. Of 32 cell lines, 6 lines expressed HGF mRNA. Two glioblastoma cell lines, HGL4 and U138, also expressed its specific receptor (c-met oncogene) mRNA. The conditioned media of HGL4 contained 3.7-fold higher HGF activity compared to FaONeO cells as a negative control. Recombinant HGF stimulated DNA synthesis of HGL4 cells in a dose-dependent manner. In addition, anti-HGF antibody inhibited DNA synthesis of these cells. These findings suggest that coexpression of HGF and c-met oncogene stimulates growth of HGL4 glioblastoma cells.

MeSH terms

  • Animals
  • Brain Neoplasms / metabolism*
  • Cells, Cultured
  • DNA / biosynthesis
  • DNA / drug effects
  • Glioblastoma / metabolism*
  • Hepatocyte Growth Factor / biosynthesis*
  • Hepatocyte Growth Factor / immunology
  • Humans
  • Proto-Oncogene Proteins c-met
  • RNA, Messenger / biosynthesis
  • Rats
  • Receptor Protein-Tyrosine Kinases / biosynthesis*
  • Recombinant Proteins / pharmacology

Substances

  • RNA, Messenger
  • Recombinant Proteins
  • Hepatocyte Growth Factor
  • DNA
  • Proto-Oncogene Proteins c-met
  • Receptor Protein-Tyrosine Kinases